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Intracellular Ca2+Podocyte number is signiﬁcantly reduced in diabetic patients and animal models, but the mechanism remains
unclear. In the present study, we found that high glucose induced apoptosis in control podocytes which
express transient receptor potential canonical 6 (TRPC6) channels, but not in TRPC6 knockdown podocytes
in which TRPC6 was knocked down by TRPC6 silencing short hairpin RNA (shRNA). This effect was
reproduced by treatment of podocytes with the reactive oxygen species (ROS), hydrogen peroxide (H2O2).
Single-channel data from cell-attached, patch-clamp experiments showed that both high glucose and H2O2
activated the TRPC6 channel in control podocytes, but not in TRPC6 knockdown podocytes. Confocal micros-
copy showed that high glucose elevated ROS in podocytes and that H2O2 reduced the membrane potential of
podocytes and elevated intracellular Ca2+ via activation of TRPC6. Since intracellular Ca2+ overload induces
apoptosis, H2O2-induced apoptosis may result from TRPC6-mediated elevation of intracellular Ca2+. These
data together suggest that high glucose induces apoptosis in podocytes by stimulating TRPC6 via elevation
of ROS.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Podocyte injury or the so-called podocytopathy includes changes
in either the morphology or the number of podocytes in the glomer-
ulus [1]. Loss of podocytes represents an early change in diabetic
patients [17,20] and animal models [24]. Hyperglycemia induces
podocyte loss via apoptosis by elevating intracellular ROS [25].
These studies suggest that the loss of podocytes due to apoptosis
may account for glomerular hyperﬁltration at the early stages of
diabetes. Since depletion of podocytes results in focal segmental
glomerulosclerosis [1,26], the loss of podocyte due to apoptosis may
also account for the pathogenesis of glomerulosclerosis at the late
stages of diabetes. Therefore, podocyte apoptosis may play an impor-
tant role in promoting the development of diabetic nephropathy from
the early glomerular hyperﬁltration to the late glomerulosclerosis.
Since the genetic form of glomerulosclerosis is caused by a mutation
in the TRPC6 gene [29], altered TRPC6 channel activity may ac-
count for the development of diabetic glomerulosclerosis. TRPC6 is alogy, Emory University School
22, United States. Tel.: +1 404
l rights reserved.Ca2+-permeable channel [12] which is highly expressed in podocytes
[21]. TRPC6-mediated increases of intracellular Ca2+ mediate podocyte
apoptosis induced by angiotensin II treatment [31], albumin overload
[3], and sustained activation of atypical N-methyl-D-aspartate (NMDA)
receptors [14]. It is known that high glucose induces podocyte apoptosis
by elevating intracellular ROS [25] and that H2O2 activates TRPC6 and
promotes TRPC6 trafﬁcking to the plasma membrane [10]. These lines
of indirect evidence suggest that TRPC6 may mediate high glucose-
induced podocyte apoptosis.
However, it appears that the role of TRPC6 in regulating cell fate
depends on cell types. In brain, inhibition of TRPC6 degradation
protects neurons against ischemic damage [7]. In vascular smooth
muscle cells, H2O2 elevates intracellular Ca2+ via TRPC6, but instead
of causing apoptosis, it induces vessel contraction [6]. In glomerular
mesangial cells of diabetic rats, the expression of TRPC6 is decreased
[11]. Since mesangial cells are smooth muscle-like cells, decreased
TRPC6 expression may reduce mesangial cell contraction and, together
with loss of podocytes, account for the glomerular hyperﬁltration found
in early diabetes mellitus. In cancer cells, activation of TRPC6 partici-
pates in malignant cell proliferation [2,4]. In the lung, TRPC6 plays a
role opposite to those in neurons, mesangial cells, and cancer cells; ac-
tivation of TRPC6 actually participates in ischemia-reperfusion induced
edema [28]. Although high glucose-induced oxidative stress increases
TRPC6 expression in human monocytes [30], instead of inducing apo-
ptosis, it causes activation of monocytes. Although ROS activate TRPC6
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dence of TRPC6, it is necessary to examine whether ROS activate
TRPC6 in podocytes and whether activation of TRPC6 accounts for
high glucose-induced apoptosis of podocytes.
In the present study, using the cell-attached patch-clamp tech-
nique combined with confocal microscopy analysis, we show that
high glucose induces apoptosis in podocytes by increasing TRPC6
channel open probability through elevation of intracellular ROS.
2. Materials and methods
2.1. Cell culture
An immortalized human podocyte cell line was provided by
Dr. Moin Saleem at Children's Renal Unit and Academic Renal Unit,
University of Bristol, Southmead Hospital, Bristol, UK. The cells were
cultured as described previously [22]. Brieﬂy, cells were cultured in
RPMI-1640 medium supplemented with 10% fetal bovine serum and
100 U/ml penicillin–streptomycin, in humidiﬁed 5% CO2 incubators
and ﬁrst incubated at 33 °C. After the cells became 70% conﬂuent,
they were incubated at 37 °C for 2 weeks before any experiment ma-
nipulations. To knock down TRPC6 expression, podocytes were stably
transfected with TRPC6 silencing short hairpin RNA (shRNA) carried
by a lentiviral vector (Santa Cruz Biotechnology). The podocytes with
reduced TRPC6 expression (TRPC6 knockdownpodocytes)were further
selected in the presence of G418. Before the TRPC6 knockdown
podocyteswere used, the reduction of TRPC6 expressionwas conﬁrmed
by Western blot experiments. All the experiments in this study were
performed at room temperature.
2.2. Patch-clamp recordings
Cell-attached patch-clamp recordings of TRPC6 single-channel cur-
rents from podocytes were carried out using an Axopatch 200B ampli-
ﬁer (Molecular Devices, Sunnyvale, CA). Prior to the experiments,
podocytes cultured on 35 mm petri dish were thoroughly washed
with NaCl bath solution containing (in mM): 145 NaCl, 3.4 KCl, 1
CaCl2, 1 MgCl2, and 10 HEPES; pH was adjusted to 7.4 with NaOH. The
glass micropipette was ﬁlled with the NaCl bath solution (the pipette
resistance is 7–10 MΩ). Most single-channel currents were obtained
with an applied pipette potential of 20 mV (−Vpipette = −20 mV).
For detecting the current–voltage relationship, several applied pipette
potentials were used. The current traces were ﬁltered at 1 kHz, and
sampled every 50 μs with Clampex 10 software. All experiments were
conducted at room temperature. The total numbers of functional chan-
nels in the patch were estimated according to the number of peaks
detected on the current amplitude histograms using at least 5 min
record. The open probability (PO) of TRPC6 before (3-minute record)
and 5 min after each experimental manipulation (3-minute record)
was calculated using Clampﬁt 10.
2.3. Confocal microscopy imaging
To evaluate apoptosis, podocytes were stained with both FITC-
conjugated annexin V (AV) and propidium iodide (PI). Confocal
microscopy experiments were performed, as we previously describe
[27], to determine how glucose induces apoptosis in podocytes. The
cell membrane of apoptotic cells was stained with AV because
phosphatidylserine, a lipid which has a high binding afﬁnity to AV,
is externalized in apoptotic cells. The nuclei of apoptotic cells were
stained with PI because the nuclear membrane of apoptotic cells
becomes permeable to PI. AV was excited with 488 nm laser and
visualized through a 515 nm emission ﬁlter, shown in green. PI
was excited with 488 nm laser and visualized through a 590 nm
emission ﬁlter, shown in red. To detect the levels of intracellular reac-
tive oxygen species (ROS), podocytes were incubated with 25 μM2′,7′-dichlorodihydroﬂuorescein diacetate a membrane-permeable,
ROS-sensitive, ﬂuorescent probe, for 15 min. To determine the mem-
brane potential, podocytes were incubated with 10 μM bis-(1,3-
dibutylbarbituric acid) trimethine oxonol, a ﬂuorescent voltage-
sensitive dye, for 30 min. Prior to the confocal microscopy experi-
ments, cells were washed twice with NaCl solution. To determine in-
tracellular Ca2+, podocytes were incubated with 5 μM ﬂuo-4 AM, a
ﬂuorescent Ca2+ indicator for 30 min. Confocal microscopy XY scan-
ning of podocytes was accomplished within 5–15 min. In each set of
experiments, images were taken using the same parameter settings.
2.4. Western blotting
Either control podocytes or TRPC6 knockdown podocytes were
cultured as described above. Cell lysates (100 μg) were loaded and
electrophoresed on 10% SDS-PAGE gels for 60 to 90 min. Gels were
blotted onto polyvinylidene ﬂuoride (PVDF) membranes for 1 h at
90 volts. After 1 h blocking with 5% BSA-PBST buffer, PVDF mem-
branes were incubated with primary antibody (1:1000 dilution) of
rabbit polyclonal antibody to TRPC6 (Sigma, Lot # 8831P1) overnight
at 4 °C, and then incubated with horseradish peroxidase (HRP)-
conjugated sheep anti-rabbit IgG secondary antibody (1:5000 dilu-
tion, GE healthcare) for 1 h after 4 vigorous washes. Finally, blots
were visualized with chemiluminescence using ECL Plus Western
Blotting Detection System (GE healthcare).
2.5. Chemicals
Most chemicals were purchased from Sigma-Aldrich (St. Louis,
MO). H2O2 was purchased from Fisher Scientiﬁc. H2O2 was diluted
with NaCl solution before it was added to the bath. All the solutions
were either premade and stored in −20 °C freezer or freshly made
before the experiments. All the concentrations listed in this study
represent the ﬁnal concentrations.
2.6. Statistical analysis
Data are reported as mean values ± SD. Statistical analysis was
performed with SigmaPlot and SigmaStat software (Jandel Scientiﬁc,
CA). Paired t-test was used for comparisons between pre and post
treatment activities. Z-test and chi-squared test were used for com-
parisons between the changes in percentage. Results were considered
signiﬁcant if p b 0.05.
3. Results
3.1. High glucose induces apoptosis of podocytes via TRPC6
High glucose causes apoptosis of podocytes [25], but the mechanism
remains largely unknown. Using confocal microscopy to analyze apo-
ptotic podocytes stained with annexin V-FITC and propidium iodide,
we found that treatment of podocytes with 33 mM glucose for 7 days
(high glucose) induced signiﬁcant apoptosis in control podocytes.
After the treatment, the percentage of apoptotic podocytes was in-
creased from 1 ± 2% to 24 ± 10% (n = 15, p b 0.001), but remained
at a low level (7 ± 5%) when the culture medium contained 10 μM
1-[2-(4-methoxyphenyl)-2-[3-(4-methoxyphenyl)propoxy]ethyl]imid-
azole (SKF-96365), a generic blocker of TRPC channels (Fig. 1, A, C). To
determine whether TRPC6 is involved in this process, podocytes were
stably transfected with TRPC6 silencing short hairpin RNA (shRNA) to
knock down TRPC6 expression in podocytes. Western blotting data
showed that TRPC6 expression was signiﬁcantly reduced in these
podocytes (Fig. 1D). In these TRPC6 knockdown podocytes, high glucose
did not induce signiﬁcant apoptosis; the percentage of apoptotic
podocytes tended to be increased, from 2 ± 3% to 5 ± 5%, but it
was not statistically signiﬁcant (n = 15, p > 0.05) (Fig. 1, B, C).
Fig. 1. High glucose induces apoptosis of podocytes via TRPC6. A, representative confocal microscopy data showing control podocytes in either control conditions (left) or treated
with high glucose (33 mM D-glucose for all the experiments in this study) for 7 days in the absence (middle) or presence of 10 μM SKF-96365 (right), a generic blocker of TRPC
channels. B shows that high glucose did not induce signiﬁcant apoptosis in TRPC6 knockdown podocytes in which TRPC6 was knocked down by its shRNA. C, percent apoptotic
cells in each experimental condition (calculated from 15 microscopy ﬁeld of four separate experiments). Apoptotic cells were stained with FITC-conjugated Annexin V (AV,
shown in green) due to phosphatidylserine externalization and propidium iodide (PI, shown in red) due to permeable nuclear membrane. DIC images were taken to show total
podocytes in each microscopy ﬁeld. Reduced TRPC6 expression was conﬁrmed by Western blotting experiments (D).
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dependent pathway.
3.2. High glucose activates TRPC6 in podocytes
To determine how high glucose regulates TRPC6 at the single-
channel level, we performed cell-attached patch-clamp experiments
both in control podocytes and TRPC6 knockdown podocytes. The
data showed that high glucose induced a channel activity in a cell-
attached patch established on a control podocyte (Fig. 2A). The single-
channel current events versus the potentials applied to the patch
pipette were plotted in Fig. 2B. The current–voltage relationship of
this channel was summarized from 6 cell-attached patches and was
shown in Fig. 2C. It has a linear conductance of 21 pS, but slight-
ly outwardly rectiﬁed (the chord conductance between 40 and
60 mV = 29 pS). In contrast, in another cell-attachedpatch established
on a TRPC6 knockdown podocyte, high glucose did not induce such a
channel activity (Fig. 2D), indicating that the channel induced by high
glucose is TRPC6. Fig. 2E shows that high glucose signiﬁcantly increased
open probability (PO) of this channel from 0.02 ± 0.04 to 0.33 ± 0.16
in control podocytes (n = 6, p b 0.01). In untreated TRPC6 knockdown
podocytes, we were unable to record any channel activity in 6 cell-
attached patches. After the treatment with high glucose, only 1 out of
6 cell-attached patches contained channel activity; the mean PO is
0.02 ± 0.04. There is no difference in PO between untreated podocytes
and the podocytes treated with high glucose (n = 6, p > 0.05). These
data together suggest that high glucose activates TRPC6 in podocytes.3.3. High glucose causes oxidative stress in podocytes
Previous studies showed that high glucose gradually elevates
intracellular ROS in immortalized mouse podocytes during the period
from 30 min to 24 h [25]. To test whether high glucose also elevates
ROS in human podocytes, cultured human podocytes were stained
with a membrane-permeable, ROS-sensitive, ﬂuorescent probe, 2′,7′-
dichlorodihydroﬂuorescein diacetate. Confocalmicroscopydata showed
that treatment of human podocytes with 33 mM glucose for 3 days
caused more than 3-fold increase of the ﬂuorescent intensity (Fig. 3,
A, B) (n = 6, p b 0.001). These data suggest that high glucose elevates
intracellular ROS in human podocytes and the elevation is maintained
for a long period.
3.4. H2O2 induces apoptosis of podocytes via TRPC6
The above experiments showed that high glucose elevated intra-
cellular ROS and induced apoptosis. To determine whether high glu-
cose induces apoptosis by elevating ROS in podocytes, we used
H2O2 as a tool to manipulate the levels of intracellular ROS. Confocal
microscopy experiments similar to those in Fig. 1 were carried out,
except that in these experiments podocytes were treated with
5 mM H2O2 for 1 h. Fig. 4 shows that treatment with 5 mM H2O2
for 1 h induced apoptosis in control podocytes; the percentage of ap-
optotic podocytes was increased, from 1 ± 2% to 14 ± 8% (n = 15,
p b 0.001), but remained at a low level (2 ± 3%) when culture medi-
um contained 10 μM SKF-96365, a generic blocker of TRPC channels
Fig. 2. High glucose induces TRPC6 channel activity in podocytes. A, representative single-channel records from two cell-attached patches when 20 mV was applied to the patch
pipette (−Vpipette = −20 mV): one from an untreated podocyte (upper); the other from a podocyte treated with high glucose for 3 days (lower). Patch pipettes were ﬁlled
with NaCl bath solution (see Materials and methods). B, single-channel current traces at different applied pipette potentials from the same patch shown in A after the podocyte
was treated with high glucose. C, summary plot of current–voltage relationship of this channel recorded from 5 glucose-treated podocytes, showing that the channel has a linear
conductance of 21 pS and is slightly outwardly voltage-rectiﬁed. D shows that high glucose failed to induce such a channel in a cell-attached patch formed on a TRPC6 knockdown
podocyte. E, summary plots of open probability (PO) of 6 cell-attached patches in each experimental condition. “-C” or “C-” shows the baseline when channel is closed. Downward
events show inward currents.
1437B.-C. Liu et al. / Biochimica et Biophysica Acta 1833 (2013) 1434–1442(Fig. 4, A–C). In contrast, H2O2 applied to the cells also for 1 h at the
same concentration (5 mM) did not induce apoptosis in TRPC6
knockdown podocytes. The percentage of apoptotic podocytes
tended to increase from 1 ± 2% to 3 ± 5%, but the increase was
not statistically signiﬁcant (n = 15, p > 0.05) (Fig. 4, B, C). We no-
ticed that a very high concentration of H2O2 was required to induce
the effect. This is not surprising because in the hippocampus, theFig. 3. High glucose causes intracellular oxidative stress. A, representative confocal microsco
for 3 days (right). Podocytes were stained with 2′,7′-dichlorodihydroﬂuorescein diacetate,
microscopy data represent consistent results from six separate experiments in each group. B
(white bar) or treated with high glucose for 3 days (black bar).IC50 for extracellular H2O2 to affect postsynaptic potentials is nearly
6 mM [18]. Our recent studies also show that a high concentration
of exogenous H2O2 is required to ﬁnally elevate intracellular ROS
and regulate the epithelial sodium channel in A6 distal nephron
cells [15]. These data together suggest that H2O2 at 5 mM did not
cause a nonspeciﬁc podocyte injury, but a TRPC6-mediated
apoptosis.py data from podocytes either in control conditions (left) or treated with high glucose
a membrane-permeable ﬂuorescent probe detecting intracellular ROS. These confocal
, summary plots of ﬂuorescence intensity of podocytes either under control conditions
Fig. 4. H2O2 also induces apoptosis of podocytes via TRPC6. A, representative confocal microscopy data showing podocytes either in control conditions (left) or treated with 5 mM
H2O2 for 1 h in the absence (middle) or presence of 10 μM SKF-96365 (right). B shows that H2O2 failed to induce apoptosis in TRPC6 knockdown podocytes. C, percent apoptotic
cells in each experimental condition, as indicated (calculated from 15 microscopy ﬁelds from three separate experiments). Apoptotic cells were stained as described in Fig. 1.
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In Figs. 2 and 3, we showed that high glucose elevated intracellular
ROS and activated TRPC6 in podocytes. Although it has been shown inFig. 5. H2O2 also induces TRPC6 channel activity in podocytes. A, application of 5 mM H2O
pipettes contained NaCl bath solution. Such channel activity was barely observed when pa
after application of 5 mM H2O2 to the bath; patch pipettes contained NaCl bath solution e
of 6 cell-attached patches; the POs in three cell-attached patches are overlapped because th
not induce the same type of channel activity in TRPC6 knockdown podocytes in any of 6 cea heterologous system that H2O2 stimulates TRPC6 [10], it remains un-
known whether H2O2 could stimulate TRPC6 in podocytes. Therefore,
cell-attached patch-clamp experimentswere carried out in both control
and TRPC6 knockdown podocytes. We found that application of 5 mM2 to the bath induced a channel in a cell-attached patch from a podocyte when patch
tch pipettes contained 10 μM SKF-96365 (B). C and D, summary plots of PO before and
ither without (C) or with 10 μM SKF-96365 (D) (note: in D, the data are from a total
e value is zero even after addition of H2O2 to the bath). E shows that 5 mM H2O2 did
ll-attached patches.
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a control podocyte (Fig. 5A). The H2O2-induced channel activity was
blocked by 10 μM SKF-96365 in the patch pipette (Fig. 5B). The PO of
this channel was signiﬁcantly increased from 0.02 ± 0.04 to 0.46 ±
0.15 (n = 6, p b 0.01) when the patch pipette contained NaCl bath
solution alone, but remained unchanged (0.01 ± 0.02 to 0.04 ±
0.05; n = 6, p > 0.05) when the patch pipette contained NaCl bath
solution plus 10 μM SKF-96365. To conﬁrm that the channel we ob-
served is TRPC6, a total of 6 cell-attached patches were established
on TRPC6 knockdown podocytes. None of these patches contained
any H2O2-induced channel activity, even when the cells were ex-
posed to 5 mM H2O2 (n = 6, PO = 0) (Fig. 5E), indicating that the
channel activated by H2O2 is TRPC6. To characterize the current–
voltage relationship, H2O2-induced single-channel current events
versus the potentials applied to the patch pipette were plotted in
Fig. 6A. The current–voltage relationship of this channel wasFig. 6. Blockade of TRPC6 channels outside the patch pipette shifts the reversal potential of
versus potentials applied to the patch pipette in a cell-attached patch before (A) and after
patch pipette across the whole cell membrane (B). C, summary plots of current–voltage r
(open circles) and after addition of 10 μM SKF-96365 to the bath (ﬁlled circles).summarized from 6 cell-attached patches and was shown in
Fig. 6C. Similar to the channel activated by high glucose, the channel
activated by H2O2 also has a linear conductance of 21 pS. It appears
that, for some unknown reason, the outward rectiﬁcation appears
to become apparent (the chord conductance between 40 and
60 mV = 42 pS). These data suggest that H2O2 can mimic the effect
of high glucose on TRPC6 channel activity.
3.6. Activation of TRPC6 reduces the membrane potential and elevates
intracellular Ca2+
In Fig. 2, we noticed that the reversal potential of high glucose-
induced TRPC6 single-channel current was near zero. Similarly, the
reversal potential of H2O2-induced TRPC6 single-channel current was
also near zero (Fig. 6C). Since TRPC6 is a non-selective cation channel
[12], theoretically, activation of TRPC6 should depolarize themembraneTRPC6 channel recorded in the patch. A and B, H2O2-induced single-channel currents
addition of 10 μM SKF-96365 to the bath to block all the TRPC6 channels outside the
elationship of H2O2-induced single-channel currents versus pipette potentials before
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blockade of TRPC6 should abolish the depolarization and shift the rever-
sal potential. Indeed, the data showed that application of 10 μM
SKF-96365 to the bath to block the TRPC6 channels outside the patch
pipette shifted the reversal potential from near zero to 27 mV (Fig. 6,
B, C) implying that the membrane potential was hyperpolarized by
27 mV. To conﬁrm the patch-clamp data, podocytes were stained with
a ﬂuorescent voltage-sensitive dye, bis-(1,3-dibutylbarbituric acid)
trimethine oxonol. At 5 min after exposure of podocytes to 5 mM
H2O2, the ﬂuorescence intensity was reduced by about 40%, indicating
that the membrane potential was depolarized. The depolarization was
abolished by 10 μM SKF-96365, even though 5 mM H2O2 is still in the
bath (Fig. 7, A, B). These data suggest that activation of TRPC6 depolar-
izes podocyte membrane potential.
Since TRPC6 is a Ca2+-permeable cation channel [12], activation of
TRPC6 should result in elevation of intracellular Ca2+. However, in a
heterologous expression system, TRPC6 channel appears to have lim-
ited Ca2+ permeability [8]. To test whether activation of native TRPC6
channel could elevate intracellular Ca2+, both control and TRPC6
knockdown podocytes were incubated with Fluo-4, a Ca2+ probe.
The data showed application of 5 mMH2O2 to the cells remarkably el-
evated intracellular Ca2+ in untreated control podocytes (Fig. 8A),
but Ca2+ was not increased in either the podocytes pretreated
with 10 μM SKF-96365 (Fig. 8B) or in TRPC6 knockdown podocytes
(Fig. 8C). Fig. 8D shows that there is about four-fold increase of the
ﬂuorescence intensity at 5 min after application of 5 mM H2O2 to
the bath in control podocytes; but H2O2 did not alter the ﬂuorescence
intensity either in podocytes pretreated with 10 μM SKF-96365 or in
TRPC6 knockdown podocytes. These data suggest that activation of
TRPC6 by H2O2 results in signiﬁcant increases in intracellular Ca2+.
4. Discussion
The role of TRPC6 in podocyte pathology has been highlighted
by recent discoveries that TRPC6 is a channel in glomerular slit dia-
phragm [21] and that a mutation in the TRPC6 gene causes familial
focal segmental glomerulosclerosis [29]. Since overexpression of TRPC6
by in vivo gene delivery causes proteinuria [16], which is one of the char-
acteristic symptoms of glomerulosclerosis, the abnormalities in TRPC6
for causing familiar focal segmental glomerulosclerosis are likely to be
gain-of-function mutations [19]. However, it is not clear whether
TRPC6 is active in podocytes from normal subjects and whether it can
be activated in diabetic conditions. Using a cultured human podocyte
cell line, we show that TRPC6 is inactive in control conditions, indicating
that basal TRPC6 activity may not be required for glomerular function.
This argument is consistent with the evidence that TRPC6-deﬁcient
mice do not show any obvious renal phenotype [5]. However, our data
indicate that the silent TRPC6 channel in human podocytes can beFig. 7. Activation of TRPC6 by H2O2 depolarizes podocyte membrane potential. A, r
(1,3-dibutylbarbituric acid) trimethine oxonol, a voltage-sensitive ﬂuorescent probe dete
from podocytes either under control condition (white bar), after addition of 5 mMH2O2 to
of H2O2.strongly activated by high glucose-induced oxidative stress. For the
ﬁrst time, our single-channel data clearly demonstrate that ROS activa-
tion of TRPC6 channels mediates high glucose-induced apoptosis of
podocytes by causing a massive elevation of intracellular Ca2+. Since
podocyte injury is known to play an important role in the development
and progression of diabetic glomerulosclerosis [9,13], the present study
suggests that elevated TRPC6 channel activity may account for diabetic
glomerulosclerosis. Further studies may suggest the clinical use of anti-
oxidants or TRPC6 channel blockers for preventing glomerular damage
in diabetic patients.
It has long been suggested that intracellular Ca2+ regulates both
cell survival and cell death [23]. Since TRPC6 is a Ca2+-permeable
channel [12], we argue that TRPC6 regulates both cell survival and
cell death depending on its activity. Moderate activation of TRPC6
should result in a moderate elevation of intracellular Ca2+ which
should promote cell survival. Since TRPC6 promotes malignant pro-
liferation [2,4], we argue that TRPC6 may be moderately activated
in cancer cells to mediate cell proliferation. In contrast, excess activa-
tion of TRPC6 should result in a massive increase in intracellular
Ca2+ which causes apoptosis. The present study suggests that high
glucose induces apoptosis of podocytes by causing intracellular
Ca2+ overload through ROS activation of TRPC6. Therefore, full char-
acterization of TRPC6 channel gating may provide convincing expla-
nation for the contrary roles of TRPC6 in cell proliferation and
apoptosis.
In addition to TRPC6 channel gating, the downstream pathway
for ROS to strongly activate TRPC6 also requires further investiga-
tion. First, it is not clear which type of ROS in the cells plays a role
in regulating TRPC6 (H2O2, superoxide, or both). It seems that
strong oxidants may be necessary to activate TRPC6 because in
order to activate the channel a very high concentration of H2O2
(a relatively mild oxidant) is required. However, it remains to be
further determined which type of ROS (superoxide, H2O2, or both)
is the native activator of TRPC6. Second, it remains obscure how
ROS regulate the channel. Since we applied H2O2 to the bath outside
the patch pipette, it is unlikely that H2O2 could directly regulate
TRPC6 by oxidizing the extracellular domains of the channel. Previ-
ous studies also showed that H2O2 failed to activate TRPC6 in
inside-out patches [10], indicating that H2O2 does not directly regu-
late TRPC6. These topics will serve as interesting directions for our
future studies.Acknowledgment
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He-Ping Ma).epresentative confocal microscopy images of podocytes stained with 10 μM bis-
cting the membrane potential. B, summary plots of normalized ﬂuorescence intensity
the bath (black bar), or after addition of 10 μM SKF-96365 to the bath in the presence
Fig. 8. H2O2 elevates intracellular Ca2+ in podocytes via TRPC6. A and B show representative confocal microscopy data from control podocytes before (the ﬁrst image) and after
addition of 5 mM H2O2 to the bath either in control conditions (A) or pretreated with 10 μM SKF-96365 (B). C shows representative confocal microscopy data from TRPC6
knockdown podocytes before (the ﬁrst image) and after addition of 5 mM H2O2 to the bath. D shows summary plots of relative ﬂuorescence intensity.
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